diltiazem has been researched along with sq 29548 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulmor, IE; Grover, GJ | 1 |
| Epstein, M; Hayashi, K; Loutzenhiser, R | 1 |
| Gilani, AU; Rasheed, H; Saeed, SA | 1 |
3 other study(ies) available for diltiazem and sq 29548
| Article | Year |
|---|---|
Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Diltiazem; Dogs; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Myocardial Contraction; Perfusion; Thromboxane A2; Time Factors | 1988 |
Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Kidney Glomerulus; Male; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction | 1997 |
Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways.
Topics: Arachidonic Acid; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cyproheptadine; Diltiazem; Drug Synergism; Estrenes; Fatty Acids, Unsaturated; Humans; Hydrazines; Methysergide; Platelet Aggregation; Pyrrolidinones; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Type C Phospholipases | 2003 |